Logo

Logo

Tuesday, 8 July, 2025

Phase-3 trial of Covaxin begins at Odisha’s SUM Hospital

In phase three, two doses would be administered to each volunteer 28 days apart but the follow-up period would extend to 12 months to look at its long term and side-effects, he said.

Phase-3 trial of Covaxin begins at Odisha’s SUM Hospital

Representational Image (Photo: iStock)